Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.680
+0.050 (3.07%)
At close: Apr 2, 2025, 4:00 PM
1.727
+0.047 (2.77%)
After-hours: Apr 2, 2025, 6:51 PM EDT

Entera Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-9.54-8.89-13.07-12.19-11.22
Upgrade
Depreciation & Amortization
0.050.060.060.050.06
Upgrade
Stock-Based Compensation
2.561.692.251.860.9
Upgrade
Other Operating Activities
0.010.030.1-0.20.05
Upgrade
Change in Accounts Receivable
-0.130.25-0.060.070.02
Upgrade
Change in Accounts Payable
0.050.07-0.150-0.17
Upgrade
Change in Unearned Revenue
---0.02-0.14-0.11
Upgrade
Change in Other Net Operating Assets
0.19-0.51-1.611.48-0.1
Upgrade
Operating Cash Flow
-6.82-7.31-12.5-9.06-10.56
Upgrade
Capital Expenditures
-0-0.02-0.05-0.02-0.05
Upgrade
Other Investing Activities
---0.06--
Upgrade
Investing Cash Flow
-0-0.02-0.1-0.02-0.05
Upgrade
Issuance of Common Stock
4.86.620.0125.384.05
Upgrade
Other Financing Activities
-0.32-0.58---
Upgrade
Financing Cash Flow
4.486.040.0125.384.05
Upgrade
Net Cash Flow
-2.35-1.29-12.5916.3-6.56
Upgrade
Free Cash Flow
-6.82-7.33-12.55-9.08-10.61
Upgrade
Free Cash Flow Margin
-3768.51%--9362.69%-1590.19%-2906.85%
Upgrade
Free Cash Flow Per Share
-0.18-0.25-0.44-0.35-0.58
Upgrade
Cash Income Tax Paid
--0.1700.09
Upgrade
Levered Free Cash Flow
-3.42-3.82-7.99-4.33-8.91
Upgrade
Unlevered Free Cash Flow
-3.42-3.82-7.99-4.33-8.9
Upgrade
Change in Net Working Capital
0.03-0.011.84-1.412.83
Upgrade
Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q